MRC CTU at UCL

UKCRC Registered Clinical Trials Unit

The MRC Clinical Trials Unit (MRC CTU) at UCL is at the forefront of resolving internationally important questions in infectious diseases and cancer, and delivering swifter and more effective translation of scientific research into patient benefits. It does this by carrying out challenging and innovative studies, and developing and implementing methodological advances in study design, conduct and analysis.

We are committed to strengthening and expanding the evidence base for healthcare nationally and internationally.

The MRC CTU at UCL develops methodology to improve the design, conduct and analysis of clinical studies, and hosts one of the MRC’s six regional Hubs for Trials Methodology Research.

The MRC CTU at UCL is a UKCRC registered trials unit.

 

Read more about the Unit

Series of short films about clinical trials

Clinical trials are essential to finding out whether new healthcare interventions (such as new drugs) work. We have produced a series of short films, exploring:

  • What are randomised controlled trials and why are they important?
  • What is the MRC Clinical Trials Unit, and what does it do?
  • Where do ideas for trials come from?

and much more...

Adding extra chemotherapy drugs to standard treatment for osteosarcoma does not improve outcomes
The results of the EURAMOS-1 trial, presented today at the 2014 Connective Tissue Oncology Society Meeting in Berlin, Germany, show that adding the drugs ifosfamide and etoposide to standard chemotherapy does not improve osteosarcoma outcomes.

Read more